Anticonvulsant property of Sutherlandia frutescens R. BR. (variety Incana E. MEY.) [Fabaceae] shoot aqueous extract

Brain Research Bulletin - Tập 75 - Trang 126-132 - 2008
John A.O. Ojewole1
1Department of Pharmacology, School of Pharmacy & Pharmacology, Faculty of Health Sciences, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa

Tài liệu tham khảo

Amabeoku, 1993, Cimetidine-induced seizures in mice: antagonism by some GABAergic agents, Biochem. Pharmacol., 46, 2171, 10.1016/0006-2952(93)90606-W

Amabeoku, 1998, Antimicrobial and anticonvulsant activities of Viscum capense, J. Ethnopharmacol., 61, 237, 10.1016/S0378-8741(98)00054-3

Bates, 2000, Insulin-like effect of pinitol, Br. J. Pharmacol., 130, 1944, 10.1038/sj.bjp.0703523

Bell, 1978, Systematic significance of canavanine in the Papilionoideae (Faboideae), Biochem. Syst. Ecol., 6, 201, 10.1016/0305-1978(78)90008-X

Bienvenu, 2002, Anticonvulsant activity of aqueous extract of Leonotis leonurus, Phytomedicine, 9, 217, 10.1078/0944-7113-00103

Chadwick, 2007, Antidiabetic effects of Sutherlandia frutescens in Wistar rats fed with a diabetogenic diet, J. Ethnopharmacol., 109, 121, 10.1016/j.jep.2006.07.012

Chinkwo, 2005, Sutherlandia frutescens extracts can induce apoptosis in cultured carcinoma cells, J. Ethnopharmacol., 98, 163, 10.1016/j.jep.2005.01.016

P.A. Crooks, G.A. Rosenthal, Use of l-canavanine as a chemotherapeutic agent for the treatment of pancreatic cancer, US Patent 5,552,440 (1994).

Fernandes, 2004, The antioxidant potential of Sutherlandia frutescens, J. Ethnopharmacol., 95, 1, 10.1016/j.jep.2004.05.024

Gericke, 2001, Sutherlandia frutescens, Aust. J. Med. Herb., 13, 9

M.H. Green, Method of treating viral infections with amino acid analogs, US Patent 5,110,600 (1988).

Harnett, 2005, Anti-HIV activities of organic and aqueous extracts of Sutherlandia frutescens and Lobostemon trigonus, J. Ethnopharmacol., 96, 113, 10.1016/j.jep.2004.08.038

Jang, 2002, Arginine antimetabolite l-canavanine induces apoptotic cell death in human Jurkat T cells via caspase-3 activation regulated by Bcl-2 or Bcl-xL, Biochem. Biophys. Res. Commun., 295, 283, 10.1016/S0006-291X(02)00650-2

Johnson, 2007, A randomized, double-blind, placebo-controlled trial of Lessertia frutescens in healthy adults, PLoS Clin. Trials, 2, e16, 10.1371/journal.pctr.0020016

Kang, 2004, Altered Na+–K+ ATPase immunoreactivity within GABAergic neurons in the gerbil hippocampal complex induced by spontaneous seizure and vigabatrin treatment, Neurochem. Int., 45, 179, 10.1016/j.neuint.2003.10.008

Katerere, 2005, Antibacterial and antioxidant activity of Sutherlandia frutescens (Fabaceae), a reputed anti-HIV/AIDS phytomedicine, Phytother. Res., 19, 779, 10.1002/ptr.1719

Katzung, 2004

Kelly, 1990, Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons, Neurosci. Lett., 116, 233, 10.1016/0304-3940(90)90416-7

Kundu, 2005, Inhibitory effects of the extracts of Sutherlandia frutescens (L.) R. Br. and Harpagophytum procumbens DC on phorbol ester-induced COX-2 expression in mouse skin: AP-1 and CREB as potential upstream targets, Cancer Lett., 218, 21, 10.1016/j.canlet.2004.07.029

Leonard, 2000

Leserman, 2003, HIV disease progression: depression, stress and possible mechanism, Biol. Psychiatry, 54, 295, 10.1016/S0006-3223(03)00323-8

Lorke, 1983, A new approach to practical acute toxicity testing, Arch. Toxicol., 54, 275, 10.1007/BF01234480

Macdonald, 1997, Mechanisms of action of new antiepileptic drugs, Curr. Opin. Neurol., 10, 121, 10.1097/00019052-199704000-00009

Macdonald, 1993, Antiepileptic drug mechanisms of action, Epilepsia, 34, 51

MacDonald, 1994, Mechanisms of action of new anticonvulsant drugs, 35

Mahomed, 2006, Anticonvulsant activity of Harpagophytum procumbens DC (Pedaliaceae) secondary root aqueous extract in mice, Brain Res. Bull., 69, 57, 10.1016/j.brainresbull.2005.10.010

McNamara, 2006, Pharmacotherapy of the epilepsies

Mills, 2005, African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology, Nutr. J., 4, 19, 10.1186/1475-2891-4-19

Navarro-Ruiz, 1995, Anticonvulsant activity of Casimiora edulis in comparison to phenytoin and phenobarbital, J. Ethnopharmacol., 45, 199, 10.1016/0378-8741(94)01216-M

Ojewole, 2004, Analgesic, anti-inflammatory and hypoglycaemic effects of Sutherlandia frutescens R. BR. (variety Incana E. MEY) [Fabaceae] shoot aqueous extract, Methods Findings Exp. Clin. Pharmacol., 26, 409, 10.1358/mf.2004.26.6.831315

Ojewole, 2006, Antinociceptive, anti-inflammatory and antidiabetic properties of Hypoxis hemerocallidea Fisch & C.A. Mey. [Hypoxidaceae] corm (‘African Potato’) aqueous extract in mice and rats, J. Ethnopharmacol., 103, 126, 10.1016/j.jep.2005.07.012

Prevoo, 2004, The effect of Sutherlandia frutescens on steroidogenesis: confirming indigenous wisdom, Endocr. Res., 30, 745, 10.1081/ERC-200044020

Rang, 2003

Reid, 2006, Evaluation of the mutagenic and antimutagenic effects of South African plants, J. Ethnopharmacol., 106, 44, 10.1016/j.jep.2005.11.030

Rho, 1994, Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-d-aspartate and GABAA receptors, Ann. Neurol., 35, 229, 10.1002/ana.410350216

Sia, 2004, Spotlight on ethnomedicine: usability of Sutherlandia frutescens in the treatment of diabetes, Rev. Diabet. Stud., 1, 145, 10.1900/RDS.2004.1.145

Stander, 2007, Influence of Sutherlandia frutescens extracts on cell numbers, morphology and gene expression in MCF-7 cells, J. Ethnopharmacol., 112, 312, 10.1016/j.jep.2007.03.013

Tai, 2004, In vitro culture studies of Sutherlandia frutescens on human tumor cell lines, J. Ethnopharmacol., 93, 9, 10.1016/j.jep.2004.02.028

Van Wyk, 2000

Van Wyk, 2002

Vellucci, 1984, Antagonism of caffeine-induced seizures in mice by Ro 15–1788, Eur. J. Pharmacol., 97, 289, 10.1016/0014-2999(84)90462-X

Watt, 1962

Thông tin
Thông tin xuất bản

Brain Research Bulletin

Tập 75

126-132

Thông tin tác giả